Konstantinos Zarogoulidis (Thessaloniki, Greece), Rainer G. Wiewrodt (Münster, Germany)
Survival in elderly patients undergoing lung resection for lung cancer
Marija Kojicic Vukoja (Sremska Kamenica, Republic of Serbia), Marija Vukoja, Ivan Kopitovic, Dejan Djuric, Dragana Milicic, Aleksandar Bokan, Radmila Cikara
|  |
Outcomes of radical treatment of early stage non-small cell lung cancer
Carissa Yap (Burnside , Australia), Carissa Yap, Paul Hakendorf, Richard Woodman, David Lance, John Leung, Jeffrey Bowden, Anand Rose
|  |
Improved survival associated with neoadjuvant chemoradiation and surgery vs other means of treatment for NSCLC N2 patients (clinical stage IIIa and IIIb)
Aivars Berzins (Moers, Germany), Aivars Berzins, Uldis Kopeika, Petar Traykov, Joachim Kolb, Karl Otto Kambartel, Thomas Voshaar, Thomas Krbek
| |
Impact of early weight loss during concurrent chemoradiotherapy on survival in advanced stage NSCLC patients
Karin Sanders (Maastricht, Netherlands), K.J.C. Sanders, L.E. Hendriks, E.G.C. Troost, G.P. Bootsma, A.M.W.J. Schols, A.-M.C. Dingemans
| |
Accelereated hyperfractionated radiotherapy with uneven crushing daily dose in chemoradiation treatment of inoperable non-small cell lung cancer
Yury Ragulin (Obninsk, Kaluga Oblast, Russian Federation), Yury Ragulin, Danil Gogolin, Igor Gulidov, Yury Mardynsky, Irina Ivanova, Larisa Kursova
| |
Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Marie Bernardi (Lyon, France), Marie Bernardi, Marie-Pierre Sunyach, Ronan Tanguy
| |
Clinical and therapeutic characteristics of patients died due to radiation-induced pneumonitis
David Angel Yabar Bedoya (Barcelona, Spain), David Yabar, Arturo Navarro, Susana Padrones, Ramón Palmero, Jordi Dorca, Samantha Aso
| |
Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule
Xavier Elharrar (Sausset-Les-Pins, France), Xavier Elharrar, Dominique Barbolosi, Joseph Ciccolini, Christophe Meille, Christian Faivre, Bruno Lacarelle, Nicolas André, Fabrice Barlesi
| |
Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Daniel Carlos Silva Vaz (Porto, Portugal), Daniel Vaz, Sérgio Campainha, Ana Antunes, Sara Conde, Ana Barroso
| |
Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study
Vítězslav Kolek (Olomouc, Czech Republic), Vitezslav Kolek, Ivona Grygarkova, Leona Koubkova, Tereza Janaskova, Jana Skrickova, Jaromir Roubec
| |
Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis
Sebastian Thiel (Berlin, Germany), Sebastian Thiel, Daniel Misch, Crolow Catharina, Torsten Blum, Christian Boch, Jens Kollmeier, Torsten Bauer
| |
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic
Jana Skřičková (Brno, Czech Republic), Jana Skrickova, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Jaromir Roubec, Libor Havel, Frantisek Salajka, Marcela Tomiskova, Monika Satankova
| |
Homozygous deletion of PTEN and poor outcomes in EGFR mutant NSCLC patients with gefitinib therapy
Ying-ying Gu (Guangzhou, China), Juhong Jiang, Yingying Gu
| |
Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC)
Angelica Tiotiu (Vandoeuvre-les-Nancy, France), Angelica Tiotiu, Isabelle Clerc-Urmès, Yves Martinet
| |
Assesment of palliative care in lung cancer in Turkey (ASPECT study)
Yilmaz Bülbül (Trabzon, Turkey), Yilmaz Bulbul, Tevfik Ozlu, Sibel Arinc, Berna A. Ozyurek, Hulya Gunbatar, Aysegul Senturk, Ayse Bahadir, Melike Ozcelik, Ufuk Yilmaz, Makbule Ozlem Akbay, Leyla Saglam, Talat Kilic, Gamze Kirkil, Neslihan Ozcelik, Dursun Tatar, Serap Argun Baris, Mehmet Yavsan, Hatice Selimoglu Sen, Serdar Berk, Murat Acat, Gulfidan Cakmak, Perran Fulden Yumuk, Yavuz Selim Intepe, Umran Toru, Sibel O. Ayik, Ilknur Basyigit, Sibel Ozkurt, Levent Cem Mutlu, Zehra Asuk Yasar, Hidir Esme, Muharrem Erol, Ozlem Oruc, Yurdanur Erdogan, Selvi Asker, Arife Ulas, Serhat Erol, Bugra Kerget, Ahmet Emin Erbaycu, Turgut Teke, Mehmet Besiroglu, Huseyin Can, Fahrettin Talay
| |
Impact on survival of history of diabetus mellitus in NSCLC patients
Efimia Boutsikou (Thessaloniki, Greece), Sofia Lampaki, Efimia Boutsikou, Paul Zarogoulidis, Ellada Eleptheriadou, Dionisis Spyratos, Konstantinos Zarogoulidis
| |
Perception of the disease and its impact on life in lung cancer patients
Silvija Zemnickiene (Vilnius, Lithuania), Silvija Zemnickiene, Rasa Gauronskaite, Ruta Kibarskyte, Irina Liustrickyte, Vaida Gedvilaite, Edvardas Danila
| |